BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24931466)

  • 21. C-erbB-2 expression and prognostic significance in osteosarcoma.
    Yalçin B; Gedikoğlu G; Kutluk T; Varan A; Akyüz C; Büyükpamukçu M
    Pediatr Blood Cancer; 2008 Aug; 51(2):222-7. PubMed ID: 18421709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidermal growth factor receptor expression in high-grade osteosarcomas is associated with a good clinical outcome.
    Kersting C; Gebert C; Agelopoulos K; Schmidt H; van Diest PJ; Juergens H; Winkelmann W; Kevric M; Gosheger G; Brandt B; Bielack S; Buerger H
    Clin Cancer Res; 2007 May; 13(10):2998-3005. PubMed ID: 17505002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiation-induced osteosarcomas in the pediatric population.
    Koshy M; Paulino AC; Mai WY; Teh BS
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1169-74. PubMed ID: 16054775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Multivariate analysis for prognostic factors among 43 patients with osteosarcoma].
    Zhang B; Pang QJ; Zhang HJ; Yuan Y
    Zhongguo Gu Shang; 2011 Dec; 24(12):982-6. PubMed ID: 22276503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prognostic factors for the local recurrence of osteosarcoma in extremities treated with combined therapy].
    Zhang Q; Niu XH; Cai YB; Hao L; Ding Y
    Zhonghua Wai Ke Za Zhi; 2007 Aug; 45(16):1114-7. PubMed ID: 18005614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term results (>25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high-grade, operable osteosarcoma.
    Bernthal NM; Federman N; Eilber FR; Nelson SD; Eckardt JJ; Eilber FC; Tap WD
    Cancer; 2012 Dec; 118(23):5888-93. PubMed ID: 22648705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors in osteosarcoma: a critical review.
    Davis AM; Bell RS; Goodwin PJ
    J Clin Oncol; 1994 Feb; 12(2):423-31. PubMed ID: 8113851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth patterns of osteosarcoma predict patient survival.
    Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Shin DS; Jeon DG
    Arch Orthop Trauma Surg; 2009 Sep; 129(9):1189-96. PubMed ID: 18682966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors in elderly osteosarcoma patients: a multi-institutional retrospective study of 86 cases.
    Iwata S; Ishii T; Kawai A; Hiruma T; Yonemoto T; Kamoda H; Asano N; Takeyama M
    Ann Surg Oncol; 2014 Jan; 21(1):263-8. PubMed ID: 23975321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Telangiectatic osteosarcoma: the St. Jude Children's Research Hospital's experience.
    Weiss A; Khoury JD; Hoffer FA; Wu J; Billups CA; Heck RK; Quintana J; Poe D; Rao BN; Daw NC
    Cancer; 2007 Apr; 109(8):1627-37. PubMed ID: 17351949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathologic fracture does not influence local recurrence and survival in high-grade extremity osteosarcoma with adequate surgical margins.
    Xie L; Guo W; Li Y; Ji T; Sun X
    J Surg Oncol; 2012 Dec; 106(7):820-5. PubMed ID: 22740310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COPS3 amplification and clinical outcome in osteosarcoma.
    Yan T; Wunder JS; Gokgoz N; Gill M; Eskandarian S; Parkes RK; Bull SB; Bell RS; Andrulis IL
    Cancer; 2007 May; 109(9):1870-6. PubMed ID: 17366602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Initial tumor size predicts histologic response and survival in localized osteosarcoma patients.
    Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jeon DG
    J Surg Oncol; 2008 Apr; 97(5):456-61. PubMed ID: 18270971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ezrin expression predicts survival in stage IIB osteosarcomas.
    Kim MS; Song WS; Cho WH; Lee SY; Jeon DG
    Clin Orthop Relat Res; 2007 Jun; 459():229-36. PubMed ID: 17353802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival rate and prognostic factors of conventional osteosarcoma in Northern Thailand: A series from Chiang Mai University Hospital.
    Pruksakorn D; Phanphaisarn A; Arpornchayanon O; Uttamo N; Leerapun T; Settakorn J
    Cancer Epidemiol; 2015 Dec; 39(6):956-63. PubMed ID: 26540607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteosarcoma of the pelvis: outcome analysis of surgical treatment.
    Fuchs B; Hoekzema N; Larson DR; Inwards CY; Sim FH
    Clin Orthop Relat Res; 2009 Feb; 467(2):510-8. PubMed ID: 18855090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of cyclin expression in human osteosarcoma.
    Molendini L; Benassi MS; Magagnoli G; Merli M; Sollazzo MR; Ragazzini P; Gamberi G; Ferrari C; Balladelli A; Bacchini P; Picci P
    Int J Oncol; 1998 May; 12(5):1007-11. PubMed ID: 9538120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic effect of inadvertent curettage without treatment delay in osteosarcoma.
    Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Shin DS; Jeon DG
    J Surg Oncol; 2009 Nov; 100(6):484-7. PubMed ID: 19653261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-grade osteosarcoma, review of 15 cases in a series of 156 osteosarcoma cases.
    Arslan HS; Aydin O; Dervışoğlu S; Oksüz DC; Kantarci F; Hiz M; Dınçbaç FO; Mandel NM
    Turk Patoloji Derg; 2011 May; 27(2):138-43. PubMed ID: 21630200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of postradiation osteosarcoma does not correlate with chemotherapy response.
    Lewis VO; Raymond K; Mirza AN; Lin P; Yasko AW
    Clin Orthop Relat Res; 2006 Sep; 450():60-6. PubMed ID: 16906104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.